140 mg 929 Pill - white capsule/oblong, 18mm
Pill with imprint 140 mg 929 is White, Capsule/Oblong and has been identified as Temozolomide 140 mg. It is supplied by Sun Pharma Global FZE.
Temozolomide is used in the treatment of Glioblastoma Multiforme; Anaplastic Astrocytoma and belongs to the drug class alkylating agents. There is positive evidence of human fetal risk during pregnancy. Temozolomide 140 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 140 mg 929
Temozolomide
- Imprint
- 140 mg 929
- Strength
- 140 mg
- Color
- White
- Size
- 18.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Alkylating agents
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Sun Pharma Global FZE
- National Drug Code (NDC)
- 47335-0929
- Inactive Ingredients
-
lactose anhydrous,
tartaric acid,
stearic acid,
gelatin,
titanium dioxide,
sodium lauryl sulfate,
sodium starch glycolate type A corn,
shellac,
alcohol,
butyl alcohol,
propylene glycol,
ammonia,
FD&C Blue No. 1
Note: Inactive ingredients may vary.
More about temozolomide
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (10)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: alkylating agents
- En español
Patient resources
- Temozolomide oral/injection drug information
- Temozolomide (Intravenous) (Advanced Reading)
- Temozolomide (Oral) (Advanced Reading)
- Temozolomide Capsules
- Temozolomide Injection
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
